אינג'י 10 מג20 מג טבליות

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

EZETIMIBE; SIMVASTATIN

Disponibil de la:

MERCK SHARP & DOHME ISRAEL LTD

Codul ATC:

C10AA01

Forma farmaceutică:

טבליה

Compoziție:

EZETIMIBE 10 MG; SIMVASTATIN 20 MG

Calea de administrare:

פומי

Tip de prescriptie medicala:

מרשם נדרש

Produs de:

MERCK SHARP & DOHME (ITALIA) S.P.A.

Grupul Terapeutică:

SIMVASTATIN

Zonă Terapeutică:

SIMVASTATIN

Indicații terapeutice:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Data de autorizare:

2012-04-30